Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hiromi Tomono

Phase II Study of Ramucirumab and Docetaxel for Previously Treated Non-Small Cell Lung Cancer Patients With Malignant Pleural Effusion: Protocol of PLEURAM Study

Thoracic Cancer

English

Vildagliptin‐induced Ground‐glass Nodules Mimicking Lung Metastases in a Cancer Patient Receiving Lactobacillus Probiotic Supplementation

English

Related publications

Phase II Study of S-1 and Docetaxel for Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology

English

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Research and Treatment

Cancer Research

Oncology

2016

English

PD-L1 and Immunotherapy in Patients With Non-Small Cell Lung Cancer and Malignant Pleural Effusion

2018

English

Phase I/Ii Study of Gefitinib (Iressa®) and Vorinostat (IVORI) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology

English

Phase II Study of Docetaxel Alternating With Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer

English

P3.01-37 Phase II Study of Amrubicin Plus Erlotinib in Previously Treated, Advanced Non-Small Cell Lung Cancer Patients With Wild-Type EGFR: TORG 1320

Journal of Thoracic Oncology

English

A Randomized, Double-Blind, Phase II Study of Ramucirumab Plus Docetaxel vs Placebo Plus Docetaxel in Japanese Patients With Stage IV Non-Small Cell Lung Cancer After Disease Progression on Platinum-Based Therapy

English

Atezolizumab in Japanese Patients With Previously Treated, Advanced Non–small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study

English

Erlotinib Treatment in Pretreated Patients With Non-Small Cell Lung Cancer: A Phase II Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hiromi Tomono

Phase II Study of Ramucirumab and Docetaxel for Previously Treated Non-Small Cell Lung Cancer Patients With Malignant Pleural Effusion: Protocol of PLEURAM Study

Vildagliptin‐induced Ground‐glass Nodules Mimicking Lung Metastases in a Cancer Patient Receiving Lactobacillus Probiotic Supplementation

Related publications

Phase II Study of S-1 and Docetaxel for Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

PD-L1 and Immunotherapy in Patients With Non-Small Cell Lung Cancer and Malignant Pleural Effusion

Phase I/Ii Study of Gefitinib (Iressa®) and Vorinostat (IVORI) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Phase II Study of Docetaxel Alternating With Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer

P3.01-37 Phase II Study of Amrubicin Plus Erlotinib in Previously Treated, Advanced Non-Small Cell Lung Cancer Patients With Wild-Type EGFR: TORG 1320

A Randomized, Double-Blind, Phase II Study of Ramucirumab Plus Docetaxel vs Placebo Plus Docetaxel in Japanese Patients With Stage IV Non-Small Cell Lung Cancer After Disease Progression on Platinum-Based Therapy

Atezolizumab in Japanese Patients With Previously Treated, Advanced Non–small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study

Erlotinib Treatment in Pretreated Patients With Non-Small Cell Lung Cancer: A Phase II Study